Meeting Banner
Abstract #2967

Dynamic Contrast-Enhanced MRI to Monitor Response to CyberKnife SBRT

Russell N. Low1, 2, Donald B. Fuller3, Naira Muradyan4

1Sharp and Children's MRI Center, San Diego, CA, United States; 2San Diego Imaging, San Diego, CA, United States; 3CyberKnife Centers of San Diego; 4iCAD, Inc

Dynamic contrast-enhanced MRI (DCE) is used to quantitatively assess prostate cancer before and after CyberKnife radiation therapy. The MRI driven parametric values Ktrans, Kep, EFV, and iAUGC can be followed to assess changes in tumor permeability occurring on a cellular level after CyberKnife SBRT. Both quantitative and qualitative display of these parametric values can be used to monitor tumor response to treatment.

Keywords

accelerator administration agents allows appears application arrows background bilateral biopsy body cancer cancers characterize chelate children clinical colorized compact complete concentration contrast correlation currently curve decrease delivers depicts detect developed display driven dynamic eight enhanced enhancing evaluate evaluated external extracellular five flow fraction fuller gadolinium generate gland grade histological identified included initial injection intravenous intrinsic lightweight linear maps materials median monitor months morphology mounted parametric patient patients percent perfusion peripheral permeability physiologic post prior progressive promising prostate proven quantitative radiation radiology radiotherapy recently repeated repeatedly resolution resolves resolving response robotic scanner section sharp since stage temporal therapy thin tissue tissues tracking trans treatment treatments tumor tumors twenty underwent variations various vascular visualization volume workstation year years zone